vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Millrose Properties, Inc. (MRP). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $189.5M, roughly 1.4× Millrose Properties, Inc.). Millrose Properties, Inc. runs the higher net margin — 64.5% vs 0.7%, a 63.8% gap on every dollar of revenue.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Millrose Properties, Inc. is a U.S.-based real estate enterprise primarily focused on the acquisition, ownership, operation, and management of income-generating multi-family residential assets. Its core markets span the U.S. Mid-Atlantic and Southeast regions, and it also offers professional property management services to select third-party property owners.
HCM vs MRP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $189.5M |
| Net Profit | $2.0M | $122.2M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 84.8% |
| Net Margin | 0.7% | 64.5% |
| Revenue YoY | -16.5% | — |
| Net Profit YoY | -83.6% | 285.8% |
| EPS (diluted) | $0.00 | $0.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $189.5M | ||
| Q3 25 | — | $179.3M | ||
| Q2 25 | $277.7M | $149.0M | ||
| Q1 25 | $324.5M | $82.7M | ||
| Q2 24 | $305.7M | — | ||
| Q2 23 | $532.9M | — | ||
| Q2 22 | $202.0M | — |
| Q4 25 | $2.0M | $122.2M | ||
| Q3 25 | — | $105.1M | ||
| Q2 25 | $455.0M | $112.8M | ||
| Q1 25 | $11.9M | $39.8M | ||
| Q2 24 | $25.8M | — | ||
| Q2 23 | $168.6M | — | ||
| Q2 22 | $-162.9M | — |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q2 24 | 41.1% | — | ||
| Q2 23 | 0.0% | — | ||
| Q2 22 | 0.1% | — |
| Q4 25 | -13.2% | 84.8% | ||
| Q3 25 | — | 85.3% | ||
| Q2 25 | -1.3% | 85.1% | ||
| Q1 25 | -5.0% | 55.2% | ||
| Q2 24 | -9.0% | — | ||
| Q2 23 | 21.0% | — | ||
| Q2 22 | -97.4% | — |
| Q4 25 | 0.7% | 64.5% | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | 163.8% | 75.7% | ||
| Q1 25 | 3.7% | 48.1% | ||
| Q2 24 | 8.4% | — | ||
| Q2 23 | 31.6% | — | ||
| Q2 22 | -80.6% | — |
| Q4 25 | $0.00 | $0.74 | ||
| Q3 25 | — | $0.63 | ||
| Q2 25 | $0.52 | $0.68 | ||
| Q1 25 | $0.01 | $0.39 | ||
| Q2 24 | $0.03 | — | ||
| Q2 23 | $0.19 | — | ||
| Q2 22 | $-0.19 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $35.0M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $5.9B |
| Total Assets | $1.8B | $9.3B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $35.0M | ||
| Q3 25 | — | $242.6M | ||
| Q2 25 | $1.4B | $66.6M | ||
| Q1 25 | $836.1M | $89.5M | ||
| Q2 24 | $802.5M | — | ||
| Q2 23 | $856.2M | — | ||
| Q2 22 | $826.2M | — |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q2 24 | $82.1M | — | ||
| Q2 23 | $40.1M | — | ||
| Q2 22 | $418.0K | — |
| Q4 25 | $1.2B | $5.9B | ||
| Q3 25 | — | $5.9B | ||
| Q2 25 | $1.2B | $5.9B | ||
| Q1 25 | $759.9M | $5.9B | ||
| Q2 24 | $740.1M | — | ||
| Q2 23 | $782.0M | — | ||
| Q2 22 | $799.7M | — |
| Q4 25 | $1.8B | $9.3B | ||
| Q3 25 | — | $9.0B | ||
| Q2 25 | $1.8B | $8.0B | ||
| Q1 25 | $1.3B | $7.2B | ||
| Q2 24 | $1.3B | — | ||
| Q2 23 | $1.3B | — | ||
| Q2 22 | $1.2B | — |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q2 23 | 0.05× | — | ||
| Q2 22 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $3.7B |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | 30.05× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $3.7B | ||
| Q3 25 | — | $123.1M | ||
| Q2 25 | $-72.9M | $109.1M | ||
| Q1 25 | $40.3M | $21.3M | ||
| Q2 24 | $-39.8M | — | ||
| Q2 23 | $226.4M | — | ||
| Q2 22 | $-89.9M | — |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q2 24 | $-49.9M | — | ||
| Q2 23 | $202.0M | — | ||
| Q2 22 | $-105.6M | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q2 24 | -16.3% | — | ||
| Q2 23 | 37.9% | — | ||
| Q2 22 | -52.3% | — |
| Q4 25 | 1.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q2 23 | 4.6% | — | ||
| Q2 22 | 7.8% | — |
| Q4 25 | 4.21× | 30.05× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | -0.16× | 0.97× | ||
| Q1 25 | 3.38× | 0.53× | ||
| Q2 24 | -1.54× | — | ||
| Q2 23 | 1.34× | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
